NCT03719144View on ClinicalTrials.gov

Understanding and Improving Anticoagulation Dosing for Patients With Atrial Fibrillation

CompletedOBSERVATIONAL

Enrollment

581

Participants

Timeline

Start Date

April 8, 2019

Primary Completion Date

March 24, 2020

Study Completion Date

March 24, 2020

Conditions

Atrial Fibrillation

Trial Locations (1)

27701

Duke University, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Duke University

OTHER

NCT03719144 - Understanding and Improving Anticoagulation Dosing for Patients With Atrial Fibrillation | Biotech Hunter | Biotech Hunter